MoneyWorks4Me

Aspira Pathlab & Diagnostics informs about disclosure

02 Mar 2024 Evaluate

Aspira Pathlab & Diagnostics has informed that it enclosed the following disclosure Form - C pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 from Nikunj Velji Mange (DIN: 08489442), Executive Director of the Company for the acquisition of Equity Shares from the market.

The above information is a part of company’s filings submitted to BSE.

Peers